Beijing Scitop Bio Tech Co Ltd Capital Reinvestment Ratio
Beijing Scitop Bio Tech Co Ltd capital reinvestment ratio. Beijing Scitop Bio Tech Co Ltd (300858) has a Capital Reinvestment Ratio of 1.59x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥44.72 Million) in capital expenditures (CN¥70.94 Million). See 300858 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Beijing Scitop Bio Tech Co Ltd (2015–2025)
Capital reinvestment ratio of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. This chart tracks Beijing Scitop Bio Tech Co Ltd's Capital Reinvestment Ratio across 11 annual periods. See Beijing Scitop Bio Tech Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Beijing Scitop Bio Tech Co Ltd Capital Reinvestment Ratio by Year (2015–2025)
Beijing Scitop Bio Tech Co Ltd capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Beijing Scitop Bio Tech Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.40x | CN¥123.44 Million | CN¥296.12 Million | ▲ +61.2% |
| 2024 | 1.49x | CN¥142.11 Million | CN¥211.50 Million | ▼ -10.6% |
| 2023 | 1.66x | CN¥107.27 Million | CN¥178.47 Million | ▲ +193.4% |
| 2022 | 0.57x | CN¥148.46 Million | CN¥84.18 Million | ▼ -7.5% |
| 2021 | 0.61x | CN¥110.27 Million | CN¥67.57 Million | ▲ +92.0% |
| 2020 | 0.32x | CN¥66.67 Million | CN¥21.28 Million | ▼ -32.2% |
| 2019 | 0.47x | CN¥98.27 Million | CN¥46.25 Million | ▼ -56.1% |
| 2018 | 1.07x | CN¥89.55 Million | CN¥95.99 Million | ▲ +90.6% |
| 2017 | 0.56x | CN¥84.00 Million | CN¥47.25 Million | ▼ -12.6% |
| 2016 | 0.64x | CN¥32.73 Million | CN¥21.06 Million | ▼ -69.5% |
| 2015 | 2.11x | CN¥2.69 Million | CN¥5.66 Million | — |